Literature DB >> 7729920

Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.

D Islam1, B Wretlind, M Ryd, A A Lindberg, B Christensson.   

Abstract

To assess the humoral immunological responses at the subclass level in shigellosis, specific antibody responses against Shigella dysenteriae 1 lipopolysaccharide (LPS), S. flexneri Y LPS, invasion plasmid-coded protein antigens (Ipa), and Shiga toxin were analyzed. Antibody responses of 41 patients with S. dysenteriae 1 infection (SDIP) and 15 patients with S. flexneri infection (SFIP) were compared with those of controls (n = 40). The levels of total immunoglobulin G (IgG), IgA, IgM, and albumin in serum and stool samples were analyzed. In addition, total IgA (t-IgA), secretory IgA (s-IgA), and antigen-specific s-IgA in fecal samples were analyzed to evaluate the specificities and magnitudes of the mucosal immune responses. By comparing the relative increases in optical density for each IgG subclass separately, it was determined that the anti-LPS (homologous) response initially increased in the order IgG2 > IgG1 > IgG3 > IgG4 and that this order changed to IgG2 > IgG3 > IgG1 > IgG4 later in the disease. The IgG subclass response against protein antigens initially showed the order IgG1 > IgG3 > IgG2 > IgG4, which changed to IgG3 > IgG1 > IgG2 > IgG4 later in the disease. A significant increase in the proportion of IgA2 among t-IgA compared with that in controls was seen in both SDIP and SFIP, while significant changes in the proportions of IgG1 and IgG2 among t-IgG compared with controls was seen only in SDIP. The anti-LPS IgA2 response was more prominent in SDIP than in SFIP. We found an early peak of antigen-specific s-IgA in fecal samples, with a shorter duration than the corresponding response in serum samples. The simultaneous increase of serum IgA, fecal t-IgA, and s-IgA in SDIP compared with those in SFIP suggests that there is a massive increase in the local IgA production, giving an increase in systemic IgA concomitant with an extensive gut mucosal inflammation leading to an increased loss of albumin, IgG, and IgA with a high ratio of t-IgA to s-IgA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729920      PMCID: PMC173264          DOI: 10.1128/iai.63.5.2054-2061.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Comparison of serum and fecal antibody responses of patients with naturally acquired Shigella sonnei infection.

Authors:  D K Winsor; J J Mathewson; H L DuPont
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

3.  Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

Authors:  A Fontaine; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 4.  IgG subclass changes in response to vaccination.

Authors:  L Hammarström; C I Smith
Journal:  Monogr Allergy       Date:  1986

5.  Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.

Authors:  D Cohen; M S Green; C Block; T Rouach; I Ofek
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

6.  Diabetic skin, joints, and eyes--how are they related?

Authors: 
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

7.  Measurement of total, monomeric and polymeric IgA in human faeces by electroimmunodiffusion.

Authors:  D Meillet; D Raichvarg; F Tallet; J Savel; J Yonger; J G Gobert
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

8.  A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.

Authors:  M M Gaspari; P T Brennan; S M Solomon; C O Elson
Journal:  J Immunol Methods       Date:  1988-05-25       Impact factor: 2.303

9.  Massive plasma cell infiltration of the digestive tract. Secretory component as the rate-limiting factor of immunoglobulin secretion in external fluids.

Authors:  J F Colombel; J C Rambaud; J P Vaerman; A Galian; D L Delacroix; J Nemeth; F Duprey; M Halphen; P Godeau; C Dive
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

10.  Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.

Authors:  J M Buysse; C K Stover; E V Oaks; M Venkatesan; D J Kopecko
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

View more
  15 in total

Review 1.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

2.  Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection.

Authors:  R Raqib; A Ljungdahl; A A Lindberg; U Andersson; J Andersson
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

3.  Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.

Authors:  D Islam; B Veress; P K Bardhan; A A Lindberg; B Christensson
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

4.  Effects of the route of infection on immunoglobulin G subclasses and specificity of the reovirus-specific humoral immune response.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a.

Authors:  S S Way; A C Borczuk; M B Goldberg
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.

Authors:  S R Hedges; M S Mayo; J Mestecky; E W Hook; M W Russell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis.

Authors:  D Islam; B Veress; P K Bardhan; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

8.  Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.

Authors:  T Azim; F Qadri; S Ahmed; M S Sarker; R C Halder; J Hamadani; A Chowdhury; M A Wahed; M A Salam; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

9.  Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea.

Authors:  Anuradha Sinha; Ayan Dey; Giulietta Saletti; Pradip Samanta; Partha Sarathi Chakraborty; M K Bhattacharya; Santanu Ghosh; T Ramamurthy; Jae-Ouk Kim; Jae Seung Yang; Dong Wook Kim; Cecil Czerkinsky; Ranjan K Nandy
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

10.  Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis.

Authors:  D Islam; B Wretlind; A A Lindberg; B Christensson
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.